8-K - PAVmed Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

On March 27, 2026, PAVmed Inc. held a Special Meeting of stockholders where they approved the issuance of common stock related to Series D Preferred Stock and convertible notes, an amendment to the Certificate of Incorporation regarding director removal, and an increase in shares available under the 2014 Long-Term Incentive Equity Plan.

Key Takeaways

1Stockholders approved the issuance of shares upon conversion of 60,000 shares of Series D Convertible Preferred Stock and pursuant to an Amended and Restated Senior Secured Convertible Note.

2An amendment to the Certificate of Incorporation was approved to permit the removal of directors with or without cause by a majority vote; the amendment was effective March 27, 2026.

3The 2014 Long-Term Incentive Equity Plan was amended to increase the share reserve by 1,500,000 shares, raising the total to 1,713,517 shares.

4Stockholders representing approximately 54.1% of the voting power outstanding were present at the Special Meeting.

5The Charter Amendment Proposal passed with 858,651 votes 'For' and 60,825 votes 'Against'.

Current Report Details

Event Type

Management Change

Shareholder Vote

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Directors; Compensatory Arrangements of Certain Officers. The inform

Management Change

5.07

. Submission of Matters to a Vote of Security Holders. On March 27, 2026, PAVmed Inc. (the “ Company ”) held a special meeting of its stockholders (the “ Specia

Shareholder Vote

9.01

. Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 3.1 Form of Certificate of Amendment (incorporated by reference to Annex A of the Pro

Exhibits Only

Exhibits (1)

8-K